SCICLONE PHARMACEUTICALS INC's ticker is SCLN and the CUSIP is 80862K104. A total of 145 filers reported holding SCICLONE PHARMACEUTICALS INC in Q2 2015. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $2,797,000 | +24.8% | 259,023 | +18.4% | 0.00% | 0.0% |
| Q3 2016 | $2,241,000 | -21.7% | 218,679 | -0.2% | 0.00% | -25.0% |
| Q2 2016 | $2,861,000 | +47.2% | 219,053 | +24.0% | 0.00% | +33.3% |
| Q1 2016 | $1,943,000 | +21.5% | 176,671 | +1.7% | 0.00% | +50.0% |
| Q4 2015 | $1,599,000 | +32.6% | 173,775 | -0.0% | 0.00% | 0.0% |
| Q3 2015 | $1,206,000 | -31.2% | 173,793 | -2.6% | 0.00% | 0.0% |
| Q2 2015 | $1,752,000 | +24.6% | 178,435 | +12.5% | 0.00% | 0.0% |
| Q1 2015 | $1,406,000 | +2.3% | 158,658 | +1.1% | 0.00% | 0.0% |
| Q4 2014 | $1,375,000 | +26.5% | 156,976 | -0.5% | 0.00% | 0.0% |
| Q3 2014 | $1,087,000 | +30.8% | 157,801 | -0.1% | 0.00% | +100.0% |
| Q2 2014 | $831,000 | +13.5% | 157,993 | -1.8% | 0.00% | 0.0% |
| Q1 2014 | $732,000 | -8.5% | 160,897 | +1.4% | 0.00% | 0.0% |
| Q4 2013 | $800,000 | -2.7% | 158,723 | -2.1% | 0.00% | 0.0% |
| Q3 2013 | $822,000 | +5.1% | 162,104 | +2.8% | 0.00% | 0.0% |
| Q2 2013 | $782,000 | – | 157,628 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 1,663,281 | $16,300,000 | 9.19% |
| Nantahala Capital Management | 1,891,328 | $18,535,000 | 2.06% |
| Nine Chapters Capital Management LLC | 40,700 | $399,000 | 0.54% |
| MENTA CAPITAL LLC | 396,336 | $3,884,000 | 0.38% |
| Sapphire Star Partners LP | 30,439 | $298,000 | 0.34% |
| TFS CAPITAL LLC | 95,432 | $935,000 | 0.30% |
| Ativo Capital Management LLC | 123,428 | $1,210,000 | 0.30% |
| GLG Partners LP | 363,188 | $3,559,000 | 0.17% |
| GSA CAPITAL PARTNERS LLP | 240,013 | $2,352,000 | 0.13% |
| Bowling Portfolio Management LLC | 68,473 | $671,000 | 0.11% |